This study introduces endogenous ADA2 expression as a prognostic factor and PEGADA2 as a novel immunotherapy for cancer.
Read the article here.
Categories: Publication
Our new paper is published in Nature Communications
Our latest article has been published in Nature Communications. The study focuses on the identification of lysyl oxidase (LOX) protein as a major chemotherapy resistance modulator in triple negative breast cancer. We showed that targeting Read more…
0 Comments